TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Operating Income (2020 - 2023)

TFA Therapeutics (RAJAF) posted Operating Income of $120448.0 for Q4 2023, up 426.41% on a QoQ basis from -$36901.0 in Q4 2022, and up 426.41% year-over-year from $22881.1 in Q4 2022.

Analysis

TFA Therapeutics (RAJAF) Operating Income (2020 - 2023) Analysis & Trends

TFA Therapeutics has reported Operating Income for 3 years, with the latest figure at $120448.0 in Q4 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Colgate Palmolive 70.50 Bn 69.13 Bn 3.30 Bn 1.02 Bn
2 Kenvue 34.15 Bn 33.04 Bn 2.30 Bn 699.00 Mn
3 Kimberly Clark 32.75 Bn 31.80 Bn 1.60 Bn 633.00 Mn
4 Bath & Body Works 3.74 Bn 2.94 Bn 692.00 Mn 216.00 Mn
5 Prestige Consumer Healthcare 2.29 Bn 2.23 Bn - -
6 Perrigo 1.92 Bn 1.52 Bn 313.90 Mn 23.50 Mn
7 Herbalife 1.28 Bn 911.72 Mn 1.03 Bn 128.30 Mn
8 Edgewell Personal Care 1.22 Bn 822.48 Mn 242.50 Mn 25.00 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 595.75 Mn 489.85 Mn 40.36 Mn 9.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 120,448.00
Dec 31, 2022 -36,901.00
Dec 31, 2020 8,732.00